Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit.

CompanyOverview|NASDAQ:MRNA] The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market.

March 5, 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

The Centers for Disease Control and Prevention is initiating expanded research into understanding autism and its potential links with vaccines, a source familiar with the CDC’s planning said.

Today, we are looking at therapeutics stocks, starting with Myriad Genetics (NASDAQ:MYGN). Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from ...

We invite students to write public-facing letters to people or groups about issues that matter to them. Contest dates: March 12 to April 16, 2025. By The Learning Network What can we learn from ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.